Mark Street-Docherty
Algemeen Directeur bij Rosa Biotech Ltd.
Profiel
Mark Street-Docherty is currently the Chief Executive Officer at Rosa Biotech Ltd.
He previously held the position of Chief Executive Officer at Delta Diagnostics (UK) Ltd.
from 2017 to 2020.
Actieve functies van Mark Street-Docherty
| Bedrijven | Functie | Begin |
|---|---|---|
Rosa Biotech Ltd.
 Rosa Biotech Ltd. Packaged SoftwareTechnology Services Rosa Biotech Ltd. is a British company that is redefining biosensing. The company is based in Bristol, UK. The company is focused on addressing intractable challenges in early disease diagnosis and industrial biotechnology. The company was founded in 2019. Mark Street-Docherty has been the CEO of the company since 2022. | Algemeen Directeur | 01-06-2022 |
Eerdere bekende functies van Mark Street-Docherty
| Bedrijven | Functie | Einde |
|---|---|---|
Delta Diagnostics (UK) Ltd.
 Delta Diagnostics (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Delta Diagnostics Ltd. develops and provides assays diagnostics solutions. It offers cystic fibrosis, rapid aneuploidy analysis, and genetic disease diagnosis. The company was founded in 1994 and is headquartered in Lancashire, the United Kingdom. | Algemeen Directeur | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Delta Diagnostics (UK) Ltd.
Delta Diagnostics (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Delta Diagnostics Ltd. develops and provides assays diagnostics solutions. It offers cystic fibrosis, rapid aneuploidy analysis, and genetic disease diagnosis. The company was founded in 1994 and is headquartered in Lancashire, the United Kingdom. | Commercial Services |
Rosa Biotech Ltd.
Rosa Biotech Ltd. Packaged SoftwareTechnology Services Rosa Biotech Ltd. is a British company that is redefining biosensing. The company is based in Bristol, UK. The company is focused on addressing intractable challenges in early disease diagnosis and industrial biotechnology. The company was founded in 2019. Mark Street-Docherty has been the CEO of the company since 2022. | Technology Services |
